A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer

NCT02555644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Prexasertib
DRUG: Cisplatin
DRUG: Cetuximab
RADIATION: Intensity Modulated Radiation Therapy

Sponsor

Eli Lilly and Company